Coronavirus HIGHLIGHTS: Zydus Cadila Application For Zycov Jab Under Evaluation, Says Niti Aayog
Coronavirus LIVE, Friday July 2: The single-shot Johnson & Johnson Covid-19 vaccine produces a strong response against the Delta variant of the virus, the company has said.
Background
Coronavirus LIVE, Friday July 2: Johnson & Johnson said that its single-shot Covid-19 vaccine neutralizes the Delta variant. It has generated strong, persistent activity against the variant, and other highly prevalent variants. The shot neutralized the delta variant within 29 days of a first dose, and protection matured and improved over time, according to the company.
The United Arab Emirates announced on Thursday a travel ban on citizens to India, Bangladesh, Nepal, Sri Lanka, Vietnam, Namibia, Zambia, Congo, Uganda, Sierra Leone, Liberia, South Africa and Nigeria, state news agency (WAM) reported.
The Foreign Ministry and the National Emergency, Crisis and Disaster Management Authority stressed that, with the start of the travel season, citizens need to comply with all precautionary and preventive measures related to COVID-19, WAM added.
Dubai had said on June 19 that an entry ban on those who in the past 14 days had visited India, Nigeria and South Africa would ease from June 23.
Zydus Cadila Application For Zycov Jab Under Evaluation, Positive Response Expected, Says Niti Aayog
DCGI has the application of Zydus Cadila. It is undergoing a process of evaluation by the Subject Expert Committee. We're hoping to hear a positive response. It will be a moment of pride as it is a unique technology. It'll give a push to our vaccine program: VK Paul, Niti Aayog
Experts Question If WHO Should Lead Pandemic Origins Probe
As the World Health Organization draws up plans for the next phase of its probe of how the coronavirus pandemic started, an increasing number of scientists say the U.N. agency it isn't up to the task and shouldn't be the one to investigate.
Numerous experts, some with strong ties to WHO, say that political tensions between the U.S. and China make it impossible for an investigation by the agency to find credible answers.
Top Headlines
